Biocon Limited: company profile and market research reports
Biocon Limited is profiled in 9 Custom Market Insights market research reports, spanning healthcare. Our analysts cover the company in the Biologics and Biosimilars, Injectable Drug Delivery Devices, India Plasma Fractionation, India Biotechnology and India Pharmaceutical markets, among others,. In each study, the Biocon Limited profile looks at its business overview, product and service portfolio, financial performance where it is disclosed, and strategic moves such as expansions, acquisitions, partnerships and new product launches. A dedicated Biocon Limited company profile brings this together in one document: a global and market level overview, core segments, financials as available, market rank and share, products and services, and recent developments.
Global level overview
- Founded
- 1990
- Website
- pubs.acs.org/journal/bcches
What the Biocon Limited profile covers
- Company overviewbusiness model, history and geographic footprint
- Key executivesleadership team and decision makers
- Product portfolioproducts and services relevant to each market
- Financial overviewrevenue, segment results and recent performance
- Operating business segmentshow the business is organised and where it earns
- Business performancemarket position, share and growth in the studied markets
- Recent developmentslaunches, partnerships, acquisitions and expansions
Top management of Biocon Limited
The leadership team of Biocon Limited, with its executives, board and key decision makers, is covered in the full company profile. Request a free sample
Recent news about Biocon Limited
- Biocon stock faces mixed Q2 as profit drops 52 percentAd Hoc News · 12 November 2026
Biocon reported a mixed second quarter for the period ended September 30, 2026, with consolidated net profit falling 52 percent year over year to INR 41 crore while revenue from operations rose 2 ...
- Biocon Q2 profit halves to ₹41 crore as delayed shipments weigh on marginsBusiness Standard · 4 November 2026
Biocon's Q2FY27 net profit fell 52 per cent to ₹41 crore as delayed shipments worth $20 million hit margins, while revenue rose 2 per cent to ₹4,389 crore.
Headlines and excerpts from the publishers. Links open their websites.
Reports that profile Biocon Limited
- Global Biologics and Biosimilars Market 2025 – 2034Healthcare · August 2025
- Global Injectable Drug Delivery Devices Market 2024–2033Healthcare · August 2024
- India Plasma Fractionation Market 2024–2033Healthcare · June 2024
- India Biotechnology Market 2024–2033Healthcare · April 2024
- India Pharmaceutical Market 2024–2033Healthcare · March 2024
- Global Pitavastatin Market 2024–2033Healthcare · December 2023
- Global Recombinant Human Insulin Market 2024–2033Healthcare · August 2023
- Global Microbial Fermentation Technology Market 2026 – 2035Healthcare · October 2022
- Global Human Insulin Market 2025 – 2034Healthcare · August 2022
What our reports say about Biocon Limited
Each report above includes a profile of Biocon Limited: business overview, products and services, financials where disclosed and recent developments. Request a free sample to see the profile.
Frequently asked questions
How many Custom Market Insights reports profile Biocon Limited?
Biocon Limited is profiled in 9 of our market research reports, including the Global Biologics and Biosimilars Market 2025 – 2034, Global Injectable Drug Delivery Devices Market 2024–2033, India Plasma Fractionation Market 2024–2033.
Which industries do these reports cover?
Healthcare.
What does the Biocon Limited company profile include?
Global level overview, Market level overview, Core segments, Financials, as available, Strategic information, Market rank and share, Products and services, Recent developments.
How much does the Biocon Limited company profile cost?
$140 for the PDF, delivered by email. More companies can be added at checkout: 2nd to 5th profile $90 each, 6th onward $70 each.
Can I see a sample first?
Yes. Request a free sample and an analyst will send it by email, usually within one business day.
